title: In vivo skin penetration of macromolecules in irritant contact dermatitis.
abstract: Recently, a selective preferential accumulation of polymeric nanoparticles (in the size range around 100nm) has been observed in the follicular system of dermatitis skin. The present investigation aimed at clearly investigating the effect of irritant contact dermatitis on the barrier permeability for colloidal systems below this size range, namely quantum dots and hydrophilic macromolecules. Irritant dermatitis was induced in mice and the penetrability of quantum dots (5nm) and hydrophilic dextran molecules has been tracked in both healthy and inflamed skin using confocal laser scanning microscopy. The selective accumulation of the quantum dots was clearly observed in inflamed skin while hydrophilic dextran behaved similarly in both healthy and inflamed skin. The therapeutic potential for the transdermal delivery of peptide drugs through inflamed skin has been also tested in rats. Results revealed that the transdermal permeation of insulin and calcitonin was not significantly enhanced in dermatitis compared to healthy skin. On the other side, permeation through stripped skin was significantly higher. However, the effect was limited and shorter compared to the SC injection where tminwas 0.5h and 2h with a 70% and 46% reduction in blood glucose levels for the stripped skin and the SC injection respectively. Similarly, tminwas 4h and 8h with area under the curve of 161±65% and 350±97% for the stripped skin and the SC injection respectively. In conclusion, the changes in skin permeability accompanied with skin inflammation did not affect its permeability to peptide drugs. Our findings also underline that experiments with the tape stripped skin model as a surrogate for inflamed skin can risk misleading conclusions due to significant difference of skin permeability between the tape stripped skin and inflamed skin.
authors: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; Institute of Pharmaceutical Technology, Pharmacy institutes, University of Bonn, Bonn, Germany; FDE (EA4267), university of Bourgogne Franche-Comté, Besançon, France. Electronic address: mona.abdelmottaleb@pharma.asu.edu.eg.
authors: Mona M A
authors: MMA
authors: Abdel-Mottaleb
authors: Institute of Pharmaceutical Technology, Pharmacy institutes, University of Bonn, Bonn, Germany; FDE (EA4267), university of Bourgogne Franche-Comté, Besançon, France.
authors: Alf
authors: A
authors: Lamprecht
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D017453:Dermatitis, Irritant / Q000378:metabolism*; D004195:Disease Models, Animal; D007509:Irritants / Q000009:adverse effects*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018613:Microscopy, Confocal / Q000379:methods; D053758:Nanoparticles / Q000378:metabolism; D010316:Particle Size; D010455:Peptides / Q000378:metabolism*; D010539:Permeability; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011108:Polymers / Q000378:metabolism; D045663:Quantum Dots / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption / Q000187:drug effects*
chemical_list: D007509:Irritants; D010455:Peptides; D004364:Pharmaceutical Preparations; D011108:Polymers
keywords: Dermatitis; Peptide; Protein; Quantum dots; Skin; Tape stripping